Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 9,085-9,096 of 23,847
Behavioral study icon
CompletedNCT05459922

Adjunctive Bright Light Therapy for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Phoenix
AddictionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Arizona State University
Condition
Addiction
Drug study icon
TerminatedNCT01928043

Adjunctive Curcumin for Symptomatic Adolescents With Bipolarity: Brain and Body Considerations

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In Toronto
BipolarityDrugFrom 13 Years to 19 Years
Countries
Canada
Sponsor
Sunnybrook Health Sciences Centre
Condition
Bipolarity
Behavioral study icon
CompletedNCT05340478

Adjunctive Family CBT for Veterans With Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
AnxietyBehavioralOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Anxiety
Drug study icon
CompletedNCT00405535

Adjunctive Glycine for OCD

This summary needs review. Please check the official study record and contact the research team for details.

In Orangeburg
OCDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
OCD
Drug study icon
TerminatedNCT01784666

Adjunctive Isradipine for Depression in bipolarity

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.

In Boston
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT07116850

Adjunctive iTBS for First-Episode Schizophrenia

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In Shijiazhuang
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
China
Sponsor
The First Hospital of Hebei Medical University
Condition
Schizophrenia
Drug study icon
TerminatedNCT01131559

Adjunctive Lisdexamfetamine (LDX) in Depression in bipolarity

This study exists to understand whether this type of care is both safe enough and useful enough to take further. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In Mason
Bipolarity, DepressionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Lindner Center of HOPE
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.